Thomas Ockier is CEO and Shareholder of Novitan, an international Clinical Trial supply company with a track record of 29 years. Specialized in giving patients safe & on time access to their clinical trial medication or Investigational Medicinal Products (IMP’s). Services include but are not limited to: release of medication, labelling & packaging, storage and distribution, comparator drugs & ancillary management, … Thomas is trainer in Decentralized Trials at European Centre for Clinical Research Training (ECCRT). Via Belgian Association of CRO’s (BeCro), Thomas is also active in supporting and lobbying to maintain Belgium’s leading position in clinical trials worldwide. Thomas holds a Master’s degree of Science in Business Engineering (Katholieke Universiteit Leuven, Belgium).